KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Common Equity (2016 - 2026)

Colgate Palmolive has reported Common Equity over the past 18 years, most recently at $486.0 million for Q1 2026.

  • For Q1 2026, Common Equity rose 101.76% year-over-year to $486.0 million; the TTM value through Mar 2026 reached $486.0 million, up 101.76%, while the annual FY2025 figure was $365.0 million, 9.94% up from the prior year.
  • Common Equity for Q1 2026 was $486.0 million at Colgate Palmolive, up from $365.0 million in the prior quarter.
  • Over five years, Common Equity peaked at $25.5 billion in Q2 2024 and troughed at -$27.6 billion in Q1 2025.
  • A 5-year average of -$3.5 billion and a median of $348.0 million in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: crashed 405400.0% in 2022 and later surged 199.78% in 2024.
  • Year by year, Common Equity stood at -$4.1 billion in 2022, then surged by 108.58% to $348.0 million in 2023, then fell by 4.6% to $332.0 million in 2024, then rose by 9.94% to $365.0 million in 2025, then soared by 33.15% to $486.0 million in 2026.
  • Business Quant data shows Common Equity for CL at $486.0 million in Q1 2026, $365.0 million in Q4 2025, and $856.0 million in Q3 2025.